Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1039

Lactase enzyme preparation produced by Aspergillus oryzae

Intended Use: Intended for use as an enzyme at up to 130 mg Total Organic Solids/kg raw material (TOS/kg) in the processing of milk, milk powder, fermented milk products and yogurt, fresh cheeses, milk-based desserts, whey, baked goods, confectionary, cereal bars and soft drinks, and at 36 mg TOS/kg raw material in the processing of milk used for non-exempt infant formulas for ages 0 to 12 months and milk-based products for ages 12 to 36 months, respectively.
Basis: Scientific procedures
Notifier: Godo Shusei Co., Ltd.
Notifier Address: 250, Aza-Nakahara, Kamihongo
Matsudo, Chiba 271-0064
Japan
GRAS Notice (releasable information): GRN 1039 with amendments (in PDF) (5.9 MB)
Date of closure: Apr 6, 2023
FDA's Letter: FDA has no questions (195 kB)
-
-